Results 111 to 120 of about 800,175 (138)

4-Aminopyridine induced hyperpolarizing oscillations in pediatric human epileptic tissue are network-driven potassium currents that are abolished by activation of KCNQ2-5 (Kv7.2-Kv7.5) channels. [PDF]

Neurobiol Dis
Kushner JK, Hoffman PB, Brzezinski CR, O'Neill BR, Hankinson TC, Wilkinson CC, Handler MH, Hoeffer CA, Alexander AL.   +8 more
europepmc   +1 more source

Activation of m1 muscarinic acetylcholine receptor induces surface transport of KCNQ channels through a CRMP-2-mediated pathway.

J Cell Sci, 2015
Jiang L, Kosenko A, Yu C, Huang L, Li X, Hoshi N.   +5 more
europepmc   +1 more source

XE991 Reverses Enhanced Short-Term Plasticity in Rat Epileptic CA1. [PDF]

Brain Sci
Schnell E, Müller S, Köhling R, Kirschstein T.   +3 more
europepmc   +1 more source

Dendrite glia interactions: lessons from the <i>C. elegans</i> amphid sense organ. [PDF]

Front Cell Dev Biol
Varandas KC.
europepmc   +1 more source

Modulation of ion channels as emerging therapeutic targets in the treatment of diabetic neuropathy. [PDF]

EXCLI J
Gupta T, Ansari A, Chalotra R, Kumar A, Singh TG, Singh R.   +5 more
europepmc   +1 more source

Physiological 17β-oestradiol inhibits K_V7.4 currents via GPER1-dependent PLC/PKC signalling. [PDF]

Channels (Austin)
Karabatak E, Lau S, Salvage SC, Jepps TA, Greenwood IA, Baldwin SN.   +5 more
europepmc   +1 more source

Oxytocinergic signalling in the respiratory parafacial region increases the activity of chemosensitive neurons and respiratory output. [PDF]

J Physiol
Araujo EV, Silva PE, Oliveira LM, Shi Y, Takakura AC, Mulkey DK, Moreira TS.   +6 more
europepmc   +1 more source

Targeted Sequencing and Haplotype Analysis of Voltage-Gated Potassium Channel Genes Reveal a Potential Association of <i>KCNV2</i> Haplotypes with Antiseizure Medication Response in Turkish Patients with Epilepsy. [PDF]

Pharmaceuticals (Basel)
Pekkoc-Uyanik KC, Todurga-Seven ZG, Agay ER, Uzun H.   +3 more
europepmc   +1 more source

Electrophysiological Abnormalities and Pharmacological Corrections of Pathogenic Missense Variants in KCNQ3. [PDF]

Neurosci Bull
Wu X, Gong J, Qiu L, Yang G, Yuan H, Shen X, Shen Y, Tian F, Gao Z.   +8 more
europepmc   +1 more source

Phosphatidylinositol 4,5-bisphosphate activation mechanism of human KCNQ5. [PDF]

Proc Natl Acad Sci U S A
Yang Z, Zheng Y, Ma D, Wang L, Zhang J, Song T, Wang Y, Zhang Y, Nan F, Su N, Gao Z, Guo J.   +11 more
europepmc   +1 more source